arrow-right-realarrow-right-whitearrow-rightback-to-topdoctordownloadfacebookinstagramlogo-markerlogo-wordmarkpodcastsearchsearch_whitetwitter
Show/Hide Menu
Close Modal

Blog

Currently filtering by tag: Adenine phosphoribosyltransferase

Twitter Poll (February 5, 2020)

Article
Adenine phosphoribosyltransferase (APRT), Twitter Poll, Arkana Laboratories
ANSWER: D 2,8-dihydroxyadeninuria (DHA) disease is a rare autosomal recessive disorder caused by complete adenine phosphoribosyltransferase (APRT) deficiency and manifests as recurrent nephrolithiasis. 2,8-DHA can lead to irreversible renal failure and frequently recurs in the transplants. Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive inherited disorder of purine metabolism. APRT catalyzes the formation of adenosine monophosphate from adenine. In the absence of APRT activity, adenine is catabolized by xanthine oxidase to 2,8-dihydroxyadenine (DHA), which is excreted in the urine. DHA is insoluble in the urine at the physiological range of pH, which may lead to crystalluria. The disease is...
Read More

Diagnose This! (October 16, 2017)

Article
What is your diagnosis?       The photomicrograph shows a distended tubule with an intratubular crystalline cast with argyrophilia. While crystalline casts can be seen from calcium phosphate, calcium oxalate and others, the presence of argyrophilia on silver stain is characteristic for 2,8-Dihydroxyadenuria (DHA) crystals. 2,8-DHA is a rare, autosomal recessive trait caused by a genetic deficiency in adenine phosphoribosyltransferase (APRT). Accurate diagnosis is critical (especially in those with limited chronicity) as treatment exists that can ameliorate renal damage in some patients. And, in patients with the undiagnosed disease who undergo a transplant, the disease will reoccur unless pharmacologic...
Read More

2,8-Dihydroxyadenuria

Article
Adenine phosphoribosyltransferase (APRT) deficiency results from an autosomal recessive enzyme defect of purine metabolism and leads to 2,8-dihydroxyadenine (2,8-DHA) crystalline nephropathy. The clinical presentation of this often misdiagnosed disease is widely variable among patients homozygous for APRT mutations, ranging from asymptomatic in some to reddish-brown diaper stains in infants to recurrent nephrolithiasis, and even CKD in the absence of nephrolithiasis. 2,8-DHA nephropathy has also been reported to recur in the renal allograft resulting in rapid allograft failure. Prompt and accurate diagnosis of this disorder is important so that treatment through pharmacologic inhibition of xanthine dehydrogenase can be initiated. The morphologic findings...
Read More
 

Arkana
Announcement

Posted December 28th 2020
We are now offering IHC and ISH testing for evaluation of the presence of SARS-CoV-2 (aka COVID-19 and novel 2019 coronavirus).
Learn More